Company profile
Sonendo, Inc.
OTC: SONX · Healthcare · Medical - Devices
#495 of 1,418 Healthcare companies by revenue26th-percentile growth
EA Score
——FH —DQ 43GM —SS 37
v0.1 · 25/100 weight · pillars only
↑ Piotroski F, workforce scale · ↓ return on equity, listing tenure
Methodology →Revenue TTM
$31.7M
Rev growth YoY (TTM)
-27.7%
Net income (FY)
-$28.0M
Employees
130
as of 2026-08-27
Market cap
$427.4k
as of 2026-08-27
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$31.7M$31.7M2024
Net income-$28.0M-$28.0M2024
Operating income-$29.4M-$29.4M2024
Total assets$31.3M$31.3M2024
Liabilities$26.1M$26.1M2024
Equity$5.2M$5.2M2024
Revenue trend
FY2021 – FY2024 · USD
FY21
FY21
FY22
FY23
FY24
Revenue by segment
Filed disclosures · FY2024
By product
Product100%
By geography
Not disclosed.
The read
What is Sonendo, Inc.’s revenue?
Sonendo, Inc. booked $31.7M in FY2024 revenue, contracting 28% year over year — slower than 74% of Healthcare companies we track, at a -88.4% net margin.
Peers · Healthcare
MediPharm Labs Corp.61CelectroCore, Inc.57CNova Leap Health Corp.75B+Cryo-Cell International, Inc.63CEyePoint Pharmaceuticals, Inc.58CVerastem, Inc.49DNeighbors
Orange →Key facts
CEOBjarne Bergheim
SectorHealthcare
IndustryMedical - Devices
HeadquartersLaguna Hills, CA
ExchangeOTC: SONX
Employees130
IPO date2021-10-29
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.